Journey Medical Corp (DERM) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$12.44M | -36.3% |
| 2024 | -$9.13M | -274.2% |
| 2023 | $5.24M | +138.7% |
| 2022 | -$13.53M | -520.5% |
| 2021 | -$2.18M | -142.5% |
| 2020 | $5.13M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$12.44M | -36.3% |
| 2024 | -$9.13M | -274.2% |
| 2023 | $5.24M | +138.7% |
| 2022 | -$13.53M | -520.5% |
| 2021 | -$2.18M | -142.5% |
| 2020 | $5.13M | — |